西班牙裔美国系统性硬化症患者疾病严重程度与死亡率的前瞻性观察研究
在遗传与环境对硬皮病结局研究队列中前瞻性收集427例系统性硬化症患者(西班牙裔124例、非西班牙裔白人220例、非西班牙裔黑人83例)的纵向临床特征。西班牙裔患者较非西班牙裔白人更年轻但病程更长、U1-RNP阳性及合并系统性红斑狼疮更常见、收入和受教育水平更低,纵向用力肺活量占预计值百分比更低(点估计-9.3%;P<0.001),感知功能残疾评分更高(点估计0.29;P<0.001),且调整年龄、性别和社会经济状态后死亡率仍更高。
要点
- 西班牙裔患者较非西班牙裔白人更常见U1-RNP阳性及系统性红斑狼疮重叠。
- 西班牙裔患者纵向用力肺活量占预计值百分比低于非西班牙裔白人(点估计-9.3%;P<0.001)。
- 调整年龄、性别和社会经济状态后,西班牙裔患者死亡率仍高于非西班牙裔白人。
核心结论
- 西班牙裔患者较非西班牙裔白人更可能U1-RNP阳性并合并系统性红斑狼疮重叠、限制性肺病更严重且死亡率更高。
研究设计与样本
- 前瞻性纵向观察研究,在遗传与环境对硬皮病结局研究队列中收集资料。
- 共427例患者,包括西班牙裔124例、非西班牙裔白人220例、非西班牙裔黑人83例。
- 所有患者符合系统性硬化症分类标准且入组时病程小于五年。
主要发现
- 入组时西班牙裔患者较非西班牙裔白人显著更年轻但病程更长、U1-RNP阳性及合并系统性红斑狼疮诊断频率更高、收入和受教育水平更低。
- 与非西班牙裔黑人相比,西班牙裔患者更常见局限性皮肤受累和抗着丝点抗体。
- 纵向分析中西班牙裔患者用力肺活量占预计值百分比显著低于非西班牙裔白人(点估计-9.3%;P<0.001),与非西班牙裔黑人无显著差异。
- 西班牙裔患者纵向改良Rodnan皮肤评分与非西班牙裔白人相似,但低于非西班牙裔黑人(点估计-3.2;P=0.029)。
- 西班牙裔患者纵向感知功能残疾评分显著高于白人(点估计0.29;P<0.001);调整年龄、性别和社会经济状态后死亡率仍高于非西班牙裔白人。
关键数值与推荐
- 西班牙裔患者用力肺活量占预计值百分比低于非西班牙裔白人:点估计-9.3%;P<0.001。
- 西班牙裔患者改良Rodnan皮肤评分低于非西班牙裔黑人:点估计-3.2;P=0.029。
- 西班牙裔患者感知功能残疾评分高于白人:点估计0.29;P<0.001。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To characterize disease manifestations in Hispanic American patients with systemic sclerosis (SSc) in comparison with non-Hispanic White and Black patients. METHODS: Longitudinal clinical characteristics were collected prospectively in the Genetics versus Environment in Scleroderma Outcome Study cohort. All patients fulfilled the classification criteria for SSc and had a disease duration less than five years at enrollment. RESULTS: A cohort of 427 patients, consisting of 124 Hispanic, 220 non-Hispanic White, and 83 non-Hispanic Black participants were examined. At enrollment, Hispanic patients were significantly younger but had longer disease duration, higher frequency of U1-RNP positivity as well as concurrent systemic lupus erythematosus (SLE) diagnosis, and lower income and educational levels in comparison to non-Hispanic White patients. Compared with non-Hispanic Black patients, Hispanic patients had more frequently limited cutaneous involvement and anticentromere antibodies. In the longitudinal analysis, Hispanic patients had significantly lower forced vital capacity percents predicted (point estimate, -9.3%; P < 0.001) than non-Hispanic White but not Black patients. Hispanic patients had similar longitudinal modified Rodnan Skin Scores like non-Hispanic White patients but lower measurements than non-Hispanic Black patients (point estimate, -3.2; P = 0.029). Hispanic patients had significantly higher serially obtained perceived functional disability scores than White patients (point estimate, 0.29; P < 0.001). Hispanic patients also had higher mortality rates than White Americans even after adjustment for age, gender, and socioeconomic statuses. CONCLUSION: Hispanic patients have higher likelihood of having U1-RNP positivity and SLE overlap, more severe restrictive lung disease, as well as higher rate of mortality than non-Hispanic White patients.
引用
- Jandali B, Lyons M, Charles J, et al. A Prospective Observational Study of Disease Severity and Mortality in Hispanic American Patients With Systemic Sclerosis. Arthritis Care Res (Hoboken). 2024. PMID: 38221717. doi:10.1002/acr.25300
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。